As UT Southwesterns Chief and Professor of Obstetrics and Gynecology, Catherine Spong, M.D., noted in Vox, that excluding pregnant patients from GLP-1 RA research over safety concerns is to provide care without adequate evidence. A 2023 observational study involving 50,000 pregnant women with Type 2 diabetes found no statistically significant differences in the number of major congenital malformations among the more than 900 women who were taking GLP-1 RAs when they learned they were pregnant
However, some patients respond well at lower doses
Our program offers comprehensive support including personalized nutrition plans and exercise regimens that work synergistically with GLP-1 medications to optimize your weight loss journey
Buckley ST, Baekdal TA, Vegge A, et al
The advantages of dermal fillers include their quick and minimally invasive nature, immediate results with little to no downtime, and the ability to be customized for specific areas of volume loss
